For Information and Appointments Call: 703-337-3305

Dear patients,

Edison HealthCare is pioneering a new level of health care for patients by avoiding inefficient and unnecessary treatments. As you likely know, Stem Cell Arts offers Regenerative procedures consisting of Stem Cells Platelets and Growth Factor injections to treat musculoskeletal diseases and injuries.  We have helped many people avoid surgery, including replacement of the knee, shoulder, and hip, as well as treating sports injuries, like ACL tears and rotator cuff tears. These treatments use a patient’s own biologic components to actually heal the injuries or damage. You may also know that we have partnered with the company Regenexx, as our research collaborator, to ensure that the treatments that our patients receive are based on the finest and most advanced processes in the world.

That said, many of you have asked “when will insurance start to cover these treatments?”  Regenexx, and we, as one of its licensed providers, are actively pursuing self-insured companies to get regenerative treatments covered.  Self-insured companies are well motivated to cover regenerative procedures.

The Regenexx treatments, using biologics from your own body offer a solution that provides a low-cost alternative to as many as 70% of orthopedic surgeries allowing employers to save more than 80% on orthopedic costs. Obviously, employers paying their own medical bills are extremely interested in these alternatives and the savings that they can create.  With this in mind, we are forwarding you the press release noted below with the link, so that you may read further on some of these relationships that are being made.  If you work for a self-insured company, or have influence at the human resource or benefits level, you may be interested in making your company aware of these opportunities and, at the same time, helping herself by getting these procedures covered for your own use. This marks the true beginning of regenerative medicine as a medical specialty.

 

Sincerely,

 

StemCellArts